Phase 4 Inhibitors Clinical Trials
8 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–8 of 8 trials
Recruiting
Phase 4
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease
AdolescentAlbuminuriaSodium-glucose Co-transporter-2 Inhibitors+1 more
Centenario Hospital Miguel Hidalgo200 enrolled1 locationNCT07405216
Recruiting
Phase 4
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
Upper GI BleedingProton Pump Inhibitors
Chinese University of Hong Kong594 enrolled8 locationsNCT05582174
Recruiting
Phase 4
PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）
HemophiliaInhibitors
Institute of Hematology & Blood Diseases Hospital, China30 enrolled1 locationNCT07406139
Recruiting
Phase 4
Effect of Ciprofol on Intraoperative Hypotension in Elderly Patients Receiving Renin-angiotensin System Inhibitors
Intraoperative hypotensionCiprofolRenin-angiotensin System Inhibitors
Second Affiliated Hospital, School of Medicine, Zhejiang University140 enrolled1 locationNCT06952608
Recruiting
Phase 4
Effect of Empagliflozin on Inflammation
InflamationCAD - Coronary Artery DiseasePCI+1 more
Hotel Dieu de France Hospital100 enrolled1 locationNCT07292909
Recruiting
Phase 4
SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients
Randomized Controlled TrialKidney Transplantation RecipientsSodium-Glucose Transporter 2 Inhibitors+2 more
Odense University Hospital88 enrolled1 locationNCT07143773
Completed
Phase 4
Relationship of serological levels for death receptors (TNFR1, TRAIL -R2, FAS ) With early pancreatic ß cell Apoptosis and Follow up after DPP4 inhibitors treatment in Syrian type 2 diabetic and impaired fasting glucose patients
the research problem is to study serum apoptotic biomarkers and inflammatory mediators in naive drug prediabetes to determine whether drug intervention (DPP4inhibitors ) can slow down or reverse apoptosis of pancreatic beta cell in order to limit conversion prediabetes to T2DM .
rama ayash -Damascus university ,-pharmacy college88 enrolled1 locationACTRN12624001135505
Recruiting
Phase 4
Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI
Weight LossHIV-1-infectionHIV+3 more
Instituto Mexicano del Seguro Social108 enrolled2 locationsNCT06602622